RESUMEN
It is thought that autism could result from an interaction between genetic and environmental factors with oxidative stress as a potential mechanism linking the two. One genetic factor may be altered oxidative-reductive capacity. This study tested the hypothesis that children with autism have increased oxidative stress. We evaluated children with autism for the presence of two oxidative stress biomarkers. Urinary excretion of 8-hydroxy-2-deoxyguanosine (8-OHdG) and 8-isoprostane-F2alpha (8-iso-PGF2alpha) were determined in 33 children with autism and 29 healthy controls. 8-iso-PGF2alpha levels were significantly higher in children with autism. The isoprostane levels in autistic subjects were variable with a bimodal distribution. The majority of autistic subjects showed a moderate increase in isoprostane levels while a smaller group of autistic children showed dramatic increases in their isoprostane levels. There was a trend of an increase in 8-OHdG levels in children with autism but it did not reach statistical significance. There was no significant correlation between the levels of the biomarkers and vitamin intake, dietary supplements, medicine, medical disorders, or history of regression. These results suggest that the lipid peroxidation biomarker is increased in this cohort of autistic children, especially in the subgroup of autistic children.
Asunto(s)
Trastorno Autístico/metabolismo , Desoxiguanosina/análogos & derivados , Dinoprost/análogos & derivados , Peroxidación de Lípido , 8-Hidroxi-2'-Desoxicoguanosina , Adolescente , Trastorno Autístico/orina , Biomarcadores/orina , Niño , Preescolar , Estudios de Cohortes , Desoxiguanosina/orina , Dinoprost/orina , Femenino , Humanos , Masculino , Estrés Oxidativo/fisiologíaRESUMEN
CD81, a tetraspanin transmembrane protein involved in cell adhesion, was found by differential display to be upregulated in the nucleus accumbens of rat brain following acute cocaine treatment (four injections of 30 mg/kg every 2 h followed by 24 h withdrawal). Cocaine-induced expression of CD81 in adult rat brain was confirmed by quantitative real-time RT-PCR. Its expression in neurons and its function in the brain are unknown. In situ hybridization shows a neuron-specific expression pattern in brain regions functionally related to the regulation of cardiovascular function and fluid homeostasis. CD81 displays codistribution to galanin and, to a lesser extent, to vasopressin. These findings add to data that suggest a connection between the brain reward pathway and the centers regulating endocrine and autonomic functions, in relation to neurochemical, behavioral, and somatic consequences of drug abuse.
Asunto(s)
Antígenos CD/genética , Cocaína/farmacología , Hipotálamo/efectos de los fármacos , Hipotálamo/fisiología , Proteínas de la Membrana , Narcóticos/farmacología , Animales , Trastornos Relacionados con Cocaína/fisiopatología , Expresión Génica/efectos de los fármacos , Hipotálamo/citología , Hibridación in Situ , Masculino , Proteínas del Tejido Nervioso/genética , Neuronas/citología , Neuronas/enzimología , Núcleo Accumbens/citología , Núcleo Accumbens/efectos de los fármacos , Núcleo Accumbens/fisiología , ARN Mensajero/análisis , Ratas , Ratas Sprague-Dawley , Tetraspanina 28 , Tirosina 3-Monooxigenasa/genéticaRESUMEN
1. A previous report demonstrated the efficacy of combining dopaminergic and serotonergic agonists in suppressing audiogenic seizures induced in ethanol-dependent rats undergoing withdrawal. Moreover, an increase in dopamine and a reduction in serotonin levels in the striatum were associated with such seizures. 2. The present study was designed to examine neurochemical changes in the striatum associated with repeated episodes of ethanol withdrawal seizures in untreated ethanol-dependent rats as well as in those treated with amphetamine and fenfluramine in combination. 3. Ethanol-dependent rats undergoing audiogenic seizures exhibited an increase in striatal dopamine and a reduction in striatal serotonin as compared to control and ethanol-dependent rats not undergoing seizures. Amphetamine and fenfluramine in combination effectively suppressed the audiogenic seizures by reversing the neurochemical changes in the striatum in ethanol-dependent rats. However, increased dopamine but decreased serotonin levels in the striatum were observed in rats undergoing one episode of ethanol withdrawal, but not in those experiencing multiple episodes of ethanol withdrawal. 4. Thus, alterations in striatal dopamine and serotonin levels were, at best, necessary but not sufficient to predispose audiogenic seizure susceptibility in ethanol-dependent rats.
Asunto(s)
Neuropatía Alcohólica/metabolismo , Alcoholismo/metabolismo , Monoaminas Biogénicas/metabolismo , Convulsiones/metabolismo , Estimulación Acústica , Alcoholismo/complicaciones , Animales , Peso Corporal/efectos de los fármacos , Química Encefálica/efectos de los fármacos , Dieta , Dopamina/metabolismo , Masculino , Ratas , Ratas Long-Evans , Convulsiones/complicaciones , Serotonina/metabolismoRESUMEN
The inverse relationship between serotonin and aggression was investigated in rats treated with aspartame, a sweetener thought to interfere with the synthesis of this neurotransmitter. Eleven adult, male Long-Evans rats received either aspartame (200-800 mg/kg, IP) or the vehicle prior to testing in a standard resident-intruder paradigm. Contrary to our hypothesis, aspartame significantly decreased aggression as shown by increased latencies to the first attack and decreased number of bites per session. Corresponding with the effects on aggression, aspartame significantly increased striatal levels of serotonin. It was concluded that high doses of aspartame reduced aggressive attack via a serotonergic mechanism while the lower dose was without effect on either variable.
Asunto(s)
Agresión/efectos de los fármacos , Aspartame/farmacología , Animales , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Masculino , Ratas , Ratas Long-Evans , Serotonina/metabolismoRESUMEN
The goal of the present study was to determine if enhancement of tryptophan levels in a nutritionally balanced liquid diet would affect alcohol intake in a two-bottle choice procedure. Furthermore. the monoaminergic agonists amphetamine, phentermine (dopaminergic- and noradrenergic-releasing drugs), and fenfluramine (a serotonin releaser) were administered to determine if these drugs reduced alcohol intake in animals fed the tryptophan-enhanced diet compared to those fed an alcohol-containing diet without added tryptophan. Amphetamine 0.5 and 2 mg/kg and phentermine 4 mg/kg selectively reduced alcohol intake in animals fed the tryptophan-enhanced diet; higher doses also reduced alcohol intake in animals fed the control alcohol diet. Three hours after drug administration, phentermine 2 and 4 mg/kg produced increases in consumption of the nonalcoholic diet in animals fed the control diet without affecting consumption in animals fed the tryptophan-enhanced diet. Finally, animals in the tryptophan-enhanced group gained less weight than those animals fed an identical diet without the added tryptophan. Neurochemical analysis revealed that the tryptophan-fed groups showed increased 5-HIAA concentrations and serotonin turnover in the striatum. hypothalamus, and frontal cortex compared to animals fed the control diet. The tryptophan-alcohol group also showed almost double the tryptophan levels in the hypothalamus compared to the tryptophan-isocaloric group. These results indicate that, whereas increasing tryptophan levels by itself was not sufficient to alter consumption of an alcohol-containing diet, the administration of monoaminergic agonists significantly interacted with tryptophan in a dose-dependent manner to reduce intake of an alcohol-containing diet without reducing intake of an isocaloric diet.
Asunto(s)
Consumo de Bebidas Alcohólicas/tratamiento farmacológico , Depresores del Apetito/uso terapéutico , Dopamina/metabolismo , Alimentos Formulados , Serotonina/metabolismo , Síndrome de Abstinencia a Sustancias/metabolismo , Triptófano/uso terapéutico , Anfetamina/uso terapéutico , Animales , Corteza Cerebral/química , Cuerpo Estriado/química , Dopamina/análisis , Fenfluramina/uso terapéutico , Hipotálamo/química , Fentermina/uso terapéutico , Ratas , Ratas Long-Evans , Serotonina/análisisRESUMEN
1. Male Swiss Webster mice were administered a series of amphetamine injections preceded by either saline or L-DOPA. 2. This injection regimen was performed for either one, two or three consecutive weeks and neurotoxic effects of the drugs were determined one week later. 3. Amphetamine treatment for two weeks produced a greater striata-dopaminergic lesion that treatment for only one week. Three weeks of treatment did not exacerbate the lesion, indicating that the damage had reached maximal levels. 4. L-DOPA pretreatment did not significantly alter any of the toxic effects of the amphetamine. Therefore, some dopaminergic neurons may be resistant to the toxic effects of amphetamine.
Asunto(s)
Encéfalo/metabolismo , Dextroanfetamina/toxicidad , Dopamina/metabolismo , Levodopa/toxicidad , Neurotoxinas/toxicidad , Serotonina/metabolismo , Ácido 3,4-Dihidroxifenilacético/metabolismo , Animales , Benserazida/farmacología , Encéfalo/efectos de los fármacos , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/metabolismo , Interacciones Farmacológicas , Lóbulo Frontal/efectos de los fármacos , Lóbulo Frontal/metabolismo , Ácido Homovanílico/metabolismo , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Masculino , Ratones , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Especificidad de Órganos , Factores de TiempoRESUMEN
The effect of ginseng total saponin (GTS) on amphetamine (AMPH)-induced disruption of fixed-interval (FI) responding in rats was examined. GTS (50 mg/kg) significantly improved the temporal responding impaired by 2 mg/kg of AMPH. A higher dose of 100 mg/kg GTS disrupted performance when given alone; this disruption was reversed by a low dose of AMPH (0.5 mg/kg) and tolerance developed to the effects of GTS with its repeated administration. Neurochemical analysis revealed that GTS (50 mg/kg) attenuated the increase in striatal dopamine caused by AMPH leading to the conclusion that brain dopamine may partially mediate the behavioral effects of GTS.
Asunto(s)
Anfetaminas/farmacología , Conducta Animal/efectos de los fármacos , Panax/química , Plantas Medicinales , Saponinas/farmacología , Animales , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Masculino , Ratas , Ratas Sprague-DawleyRESUMEN
The effect of ginseng total saponin (GTS) on amphetamine (AMPH)-induced disruption of fixed-interval (Fl) responding in rats was examined. GTS (50 mg/kg) significantly improved the temporal responding impaired by 2 mg/kg of AMPH. A higher dose of 100 mg/kg GTS disrupted performance when given alone; this disruption was reversed by a low dose of AMPH (0.5 mg/kg) and tolerance developed to the effects of GTS with its repeated administration. Neurochemical analysis revealed that GTS (50 mg/kg) attenuated the increase in striatal dopamine caused by AMPH leading to the conclusion that brain dopamine may partially mediate the behavioral effects of GTS.
RESUMEN
1. The authors investigated the ambulatory activity and water intake of rats during each 12 hr light and dark cycle for one week following four s.c. injections of 4 or 8 mg/kg of methamphetamine (METH). 2. Administration of the higher METH dose caused an increase in activity during the dark cycle on days 1 through 6 with the maximal increase on day 3 while the increase in activity during the light cycle was observed only on day 1. 3. Water intake increased the first day after administration of both METH doses, but returned to baseline by day 3. 4. Administration of both METH doses induced hyperthermia and the 8 mg/kg dose produced depletions of striatal dopamine and striatal, hippocampal and hypothalamic serotonin on day 3 but only in hippocampal serotonin by day 7. 5. These results demonstrate that high doses of METH produce a long-lasting increase in activity during the dark cycle and a transient increase in water intake. The behavioral changes which occurred during the dark cycle appear to be related to the depletion of central dopamine and/or serotonin.
Asunto(s)
Monoaminas Biogénicas/metabolismo , Encéfalo/metabolismo , Ritmo Circadiano/efectos de los fármacos , Conducta de Ingestión de Líquido/efectos de los fármacos , Metanfetamina/farmacología , Actividad Motora/efectos de los fármacos , Ácido 3,4-Dihidroxifenilacético/metabolismo , Animales , Temperatura Corporal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Ritmo Circadiano/fisiología , Cuerpo Estriado/metabolismo , Oscuridad , Dopamina/análogos & derivados , Dopamina/metabolismo , Relación Dosis-Respuesta a Droga , Hipocampo/metabolismo , Ácido Homovanílico/metabolismo , Ácido Hidroxiindolacético/metabolismo , Hipotálamo/metabolismo , Luz , Masculino , Ratas , Ratas Wistar , Serotonina/metabolismoRESUMEN
Previous studies have reported the use of combined serotonergic and dopaminergic agonists in the treatment of obesity and alcoholism. Along these lines, phentermine plus fenfluramine has been suggested as a possible clinical treatment for alcohol craving. To determine the neurochemical effects of a combined treatment of phentermine plus fenfluramine, animals were injected subcutaneously with saline, phentermine 12 mg/kg, fenfluramine 16 mg/kg, or a combination of phentermine plus fenfluramine. One hour after injection, animals were sacrificed and neurochemical analysis performed. Furthermore, separate groups of animals were given the same injections 8 times, 12 hours apart, to determine the effects on body weight and to detect a possible exacerbation of fenfluramine induced toxicity. The drug combination produced a significant rise in dopamine in the striatum, greater than that seen with either drug alone. Furthermore, the addition of phentermine reduced the fenfluramine induced rise in striatal 3,4-dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindolacetic acid (5-HIAA). Phentermine plus fenfluramine combination produced a greater weight loss than either drug alone, however, it did not produce a significantly greater drop in striatal serotonin or 5-HIAA levels above that induced by fenfluramine alone. Thus, while previous studies report the potentiated neurotoxicity of phentermine plus fenfluramine over fenfluramine alone, the present study does not indicate that such an effect occurs following an administration regimen analogous to that of patients treated with the drug combination.
Asunto(s)
Adrenérgicos/toxicidad , Encéfalo/efectos de los fármacos , Estimulantes del Sistema Nervioso Central/toxicidad , Dopaminérgicos/toxicidad , Fenfluramina/toxicidad , Fentermina/toxicidad , Serotoninérgicos/toxicidad , Animales , Peso Corporal/efectos de los fármacos , Encéfalo/metabolismo , Dopamina/metabolismo , Sinergismo Farmacológico , Fenfluramina/administración & dosificación , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Neostriado/efectos de los fármacos , Neostriado/metabolismo , Fentermina/administración & dosificación , Ratas , Ratas Sprague-Dawley , Serotonina/metabolismoRESUMEN
Experiments were carried out with a nutritionally balanced diet to test the response of rats to levels of ethanol between 0% and 6%, and to different levels and sources of protein and amino acid supplements in relation to alcohol utilization and withdrawal seizures. The high-calorie/high-carbohydrate liquid diet was well tolerated when the alcohol level was less than 30% of total calories, or 4.5% of diet. When alcohol was provided at 6% of diet, or 33% of total calories, growth and withdrawal seizure rates were negatively affected in comparison with the lower ethanol levels, even though ethanol consumption (in g/kg/day) was not different. The 6% alcohol diet was then altered through the addition of more protein calories, from 13% to 20%. This supplementation improved growth rate of the animals and reduced the rate of withdrawal seizures. The improvement from the additional protein was observed with both casein and soy protein, and was not attributable to any one or even several amino acids that might serve as transmitter precursors. A mixture of all essential amino acids representing the difference in amino acids between 13% and 20% casein protein calories was an effective as the equivalent amount of intact protein. The nonessential amino acids equivalent to 7% casein protein calories, when added to the 13% protein calories diet, increased the rate of withdrawal seizures, presumably by exacerbating the protein deficiency in the 13% protein diet. It was concluded that a 1000-1200 kcal/kg diet with 20% kcal from protein and 50% kcal from carbohydrate provides an optimal nutrient balance for efficient utilization of a 6% ethanol liquid diet for rats.
Asunto(s)
Alcoholismo , Proteínas en la Dieta/administración & dosificación , Etanol/administración & dosificación , Aminoácidos/administración & dosificación , Animales , Caseínas/administración & dosificación , Ingestión de Energía , Etanol/sangre , Masculino , Ratas , Proteínas de Soja/administración & dosificación , Síndrome de Abstinencia a SustanciasRESUMEN
Pretreatment with ginseng total saponin (GTS) reduced the magnitude of the methamphetamine-induced dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillinic acid (HVA) depletions. It is suggested that GTS can, in part, prevent the methamphetamine-induced striatal dopaminergic depletions.
Asunto(s)
Inhibidores de Captación de Dopamina/antagonistas & inhibidores , Metanfetamina/antagonistas & inhibidores , Panax/química , Plantas Medicinales , Saponinas/farmacología , Ácido 3,4-Dihidroxifenilacético/metabolismo , Animales , Cromatografía Líquida de Alta Presión , Cuerpo Estriado/metabolismo , Dopamina/metabolismo , Electroquímica , Ácido Homovanílico/metabolismo , Inyecciones Intraperitoneales , Masculino , Ratones , Saponinas/administración & dosificaciónRESUMEN
We studied the metabolic effects of high dietary intakes of pyridoxine and of the substrate-cofactor interaction between dietary histidine or tryptophan and pyridoxine in rat brain. In the substrate-cofactor interaction study, histamine and serotonin levels were determined in rats fed elevated or requirement levels of substrate (histidine: 0.3% and 0.8%, tryptophan: 0.15% and 0.6%) and excess or requirement levels of pyridoxine HCl (7 mg vs. 3,000 mg/kg). Excess pyridoxine intake caused a differential effect on brain histamine concentration--inhibitory with the requirement level of histidine (-29%), and stimulatory (+21%) with the elevated level of histidine. When dietary tryptophan was fed at the requirement level, excess pyridoxine caused essentially no changes in hypothalamic serotonin and 5HIAA (-2%, -2%). With elevated tryptophan intake, excess pyridoxine significantly increased serotonin and 5HIAA (+32%, +20%) in the hypothalamus. These results indicate a clear interaction between substrate and coenzyme precursor which influences brain metabolism of histamine and serotonin.
Asunto(s)
Encéfalo/efectos de los fármacos , Histidina/farmacología , Piridoxina/farmacología , Triptófano/farmacología , Animales , Encéfalo/metabolismo , Dieta , Interacciones Farmacológicas , Histamina/metabolismo , Hipotálamo/metabolismo , Masculino , Fosfato de Piridoxal/metabolismo , Ratas , Ratas Endogámicas , Serotonina/metabolismoRESUMEN
An animal model of haloperidol-induced tardive dyskinesia was studied in relation to the dietary manipulation of tryptophan and its effect on the movement disorder. This study showed a significant negative behavioral response to the neuroleptic drug, haloperidol. Increased dietary tryptophan (1.0 vs. 0.3%) significantly reduced the frequency of drug-induced head movements. Brain serotonin levels were elevated by the drug treatment. Brain serotonin levels correlated significantly with the behavioral response. Contrary to expectation, brain dopamine levels did not correlate with the behavioral response. These findings suggest a possible serotonergic involvement in neuroleptic-induced tardive dyskinesia and an amelioration of the disorder through tryptophan supplementation.
Asunto(s)
Discinesia Inducida por Medicamentos/tratamiento farmacológico , Haloperidol , Triptófano/uso terapéutico , Ácido 3,4-Dihidroxifenilacético/metabolismo , Animales , Núcleo Caudado/metabolismo , Dopamina/metabolismo , Discinesia Inducida por Medicamentos/fisiopatología , Hipotálamo/metabolismo , Masculino , Ratas , Ratas Endogámicas , Serotonina/metabolismoRESUMEN
The crystal structure of Pseudomonas putida cytochrome P-450cam in the ferric, camphor bound form has been determined and partially refined to R = 0.23 at 2.6 A. The single 414 amino acid polypeptide chain (Mr = 45,000) approximates a triangular prism with a maximum dimension of approximately 60 A and a minimum of approximately 30 A. Twelve helical segments (A through L) account for approximately 40% of the structure while antiparallel beta pairs account for only approximately 10%. The unexposed iron protoporphyrin IX is sandwiched between two parallel helices designated the proximal and distal helices. The heme iron atom is pentacoordinate with the axial sulfur ligand provided by Cys 357 which extends from the N-terminal end of the proximal (L) helix. A substrate molecule, 2-bornanone (camphor), is buried in an internal pocket just above the heme distal surface adjacent to the oxygen binding site. The substrate molecule is held in place by a hydrogen bond between the side chain hydroxyl group of Tyr 96 and the camphor carbonyl oxygen atom in addition to complementary hydrophobic contacts between the camphor molecule and neighboring aliphatic and aromatic residues. The camphor is oriented such that the exo-surface of C5 would contact an iron bound, "activated" oxygen atom for stereoselective hydroxylation.
Asunto(s)
Sistema Enzimático del Citocromo P-450/aislamiento & purificación , Pseudomonas/metabolismo , Secuencia de Aminoácidos , Sitios de Unión , Alcanfor , Cristalización , Modelos Moleculares , Peso Molecular , Unión Proteica , Conformación Proteica , Difracción de Rayos X/métodosRESUMEN
Dose-effect curves of d-methamphetamine (MA) on intake of sweetened condensed milk by rats were obtained before and after twice a day treatment for four days with either saline (control) or a high (50 mg/kg) dose of MA previously shown to decrease the dopamine levels of the caudate. The animals that were more sensitive to MA's anorexic effect during the before-treatment determination were found to be more sensitive to the lethal effects of the high-dose treatment. This treatment produced a six month decrease in brain dopamine but no change in the anorexic effect on milk intake or in the stereotypic behavior elicited by the drug. Subsequently, the daily administration of 2.5 mg/kg of MA, 15 min before presentation of the milk, to both control and treatment groups produced tolerance to the drug's anorexic effect. After 4 to 5 weeks of repeated administration of this dose there was a significant difference between the control group's intake of milk and treatment group's intake as well as body weight. These differences indicate an effect on the treatment upon the formation of tolerance to the anorexic effects of MA.